COVID-19 Infection

• EMA approval · 2026-08-06
  EMA Authorised: Spikevax (previously COVID-19 Vaccine Moderna) (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2) — Moderna Biotech Spain, S.L.

  European Medicines Agency authorises Spikevax (Moderna COVID-19 vaccine) for use in the EU.

• EMA approval · 2026-06-15
  EMA Authorised: Tuyory — Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)

  Tuyory has been authorised by the EMA for multiple indications including rheumatoid arthritis, juvenile arthritis, cytokine release syndrome…

• EMA approval · 2026-06-09
  EMA Authorised: Avtozma (tocilizumab) — Celltrion Healthcare Hungary Kft.

  Avtozma (tocilizumab) has been authorised in the EU for rheumatoid arthritis, juvenile idiopathic arthritis, cytokine release syndrome, and …